MrC's Smallcap Sweeps for Feb 2022
Posted: February 1st, 2022, 7:49 am
Smallcap Sweep. 01-Feb-22
Joules losing energy, Warpaint advances
Joules (JOUL) last 9 weeks rev up 31%, behind mgmt expectations. Pretax also below. Blames covid, delays to new stock arrivals, margin squeeze. "The Board's base case expectation is for trading for the balance of the year to recover in line with its previously stated expectations, supported by recovering footfall and an improved level of newness in the stock position." [SP=118 Cap=132m]
Spectral MD (SMD) guides FY(Dec) loss materially better than mkt exp. Cites lower costs per subject associated with the Diabetic Foot Ulcer study. [SP=35.9 Cap=48m]
MaxCyte (MXCT) sells license for its Flow Electroporation technology and ExPERT platform to Intima Bioscience. NO £££. [SP=462 Cap=470m]
Sureserve (SUR) wins 10-year £20m contract for Tower Hamlets Homes. [SP=91.27 Cap=150m]
Mobile Tornado (MBT) guides H1(Dec) rev £1.3m and EBITDA -£30k. Guides FY rev c.£2.52m. "The Board were disappointed to lose the customer in Canada, as announced on 1 December 2021. The loss of this customer has created a shortfall as the Company moves into the new financial year." [SP=1.54 Cap=6m]
Warpaint London (W7L) beats prev FY(Dec) rev guidance of c. £40m with £50m result. Adj pretax c.£6.6m, ahead of market expectations. "We expect to see a continuing improvement in performance in 2022 and have started the year strongly." [SP=155.5 Cap=119m]
Path Investments (PATH) extends deadline for takeover of DG Innovate to end Mar. Provides further £450k (max) loan to DG Innovate. [SP=0.28 Cap=5m]
EQTEC (EQT) long update. Guides FY21 rev in line. [SP=0.98 Cap=84m]
The Property Franchise Group (TPFG) guides FY(Dec) rev up 119%. Guides ahead of market expectations but no number. [SP=318 Cap=102m]
Triple Point Energy Efficiency (TEEC) ops update. Chmn in 'pleased'. [SP=93.95 Cap=94m]
Checkit (CKT) wins £2.8m+ 3 yr contract in USA. [SP=43.5 Cap=47m]
Mears (MER) guides FY(Dec) rev over £870m and adj pretax c. £25.5m, ahead of market consensus of £848m and £25.1m. Current trading in line. [SP=194.85 Cap=216m]
Plant Health Care (PHC) guides FY(Dec) rev up 28% and gross mgn up 300bp. Remain on track to deliver cash breakeven within existing resources. [SP=9 Cap=27m]
Elixirr (ELIX) guides FY(Dec) rev £50.5m, above market expectation of £47-50m. Adj EBITDA £15.5m, above market expectation of £15m and within the range of 30-32% of revenue previously announced. [SP=673 Cap=311m]
Fragrant Prosperity (FPP) H1 has material uncertainty going concern stmt. [SP=3.93 Cap=2m]
In line: KWG, XLM, SPEC, NWF, INL
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.
RNSs
http://www.investegate.co.uk/index.aspx?limit=-1
@MrContrarian
Joules losing energy, Warpaint advances
Joules (JOUL) last 9 weeks rev up 31%, behind mgmt expectations. Pretax also below. Blames covid, delays to new stock arrivals, margin squeeze. "The Board's base case expectation is for trading for the balance of the year to recover in line with its previously stated expectations, supported by recovering footfall and an improved level of newness in the stock position." [SP=118 Cap=132m]
Spectral MD (SMD) guides FY(Dec) loss materially better than mkt exp. Cites lower costs per subject associated with the Diabetic Foot Ulcer study. [SP=35.9 Cap=48m]
MaxCyte (MXCT) sells license for its Flow Electroporation technology and ExPERT platform to Intima Bioscience. NO £££. [SP=462 Cap=470m]
Sureserve (SUR) wins 10-year £20m contract for Tower Hamlets Homes. [SP=91.27 Cap=150m]
Mobile Tornado (MBT) guides H1(Dec) rev £1.3m and EBITDA -£30k. Guides FY rev c.£2.52m. "The Board were disappointed to lose the customer in Canada, as announced on 1 December 2021. The loss of this customer has created a shortfall as the Company moves into the new financial year." [SP=1.54 Cap=6m]
Warpaint London (W7L) beats prev FY(Dec) rev guidance of c. £40m with £50m result. Adj pretax c.£6.6m, ahead of market expectations. "We expect to see a continuing improvement in performance in 2022 and have started the year strongly." [SP=155.5 Cap=119m]
Path Investments (PATH) extends deadline for takeover of DG Innovate to end Mar. Provides further £450k (max) loan to DG Innovate. [SP=0.28 Cap=5m]
EQTEC (EQT) long update. Guides FY21 rev in line. [SP=0.98 Cap=84m]
The Property Franchise Group (TPFG) guides FY(Dec) rev up 119%. Guides ahead of market expectations but no number. [SP=318 Cap=102m]
Triple Point Energy Efficiency (TEEC) ops update. Chmn in 'pleased'. [SP=93.95 Cap=94m]
Checkit (CKT) wins £2.8m+ 3 yr contract in USA. [SP=43.5 Cap=47m]
Mears (MER) guides FY(Dec) rev over £870m and adj pretax c. £25.5m, ahead of market consensus of £848m and £25.1m. Current trading in line. [SP=194.85 Cap=216m]
Plant Health Care (PHC) guides FY(Dec) rev up 28% and gross mgn up 300bp. Remain on track to deliver cash breakeven within existing resources. [SP=9 Cap=27m]
Elixirr (ELIX) guides FY(Dec) rev £50.5m, above market expectation of £47-50m. Adj EBITDA £15.5m, above market expectation of £15m and within the range of 30-32% of revenue previously announced. [SP=673 Cap=311m]
Fragrant Prosperity (FPP) H1 has material uncertainty going concern stmt. [SP=3.93 Cap=2m]
In line: KWG, XLM, SPEC, NWF, INL
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.
RNSs
http://www.investegate.co.uk/index.aspx?limit=-1
@MrContrarian